ORRSTOWN FINANCIAL SERVICES INC
For the period ended Sep 30, 2025. Filed Nov 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 6, 2025
ORRF$44.32-0.3%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows (Unaudited)
Condensed Consolidated Statements of Cash Flows (Unaudited)
| Nine Months Ended | ||
|---|---|---|
| (Dollars in thousands) | September 30, 2025 | September 30, 2024 |
| Cash flows from operating activities | ||
| Net income | $59,364 | $8,366 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Net discount accretion | (17,601) | (5,526) |
| Depreciation and amortization expense | 11,622 | 5,793 |
| Provision for credit losses - loans | 51 | 15,348 |
| Recovery of credit losses - unfunded loan commitments | (100) | (557) |
| Share-based compensation | 3,976 | 7,488 |
| Gains on sales of loans originated for sale | (841) | (667) |
| Fair value adjustments on loans held for sale | (31) | (95) |
| Mortgage loans originated for sale | (40,043) | (29,372) |
| Proceeds from sales of loans originated for sale | 41,503 | 32,389 |
| Net gain on sale of OREO and premises held for sale | (119) | — |
| Net (gain) loss on disposal of premises and equipment | (7) | 400 |
| Deferred income tax expense | 6,646 | 38 |
| Investment securities gains | (71) | (254) |
| Net losses on derivatives | 343 | 1,316 |
| Gain on derivative terminations | — | — |
| Income from life insurance | (4,071) | (2,569) |
| Decrease (increase) in accrued interest receivable and other assets | 7,948 | (12,583) |
| (Decrease) increase in accrued interest payable and other liabilities | (11,147) | 6,398 |
| Other, net | 823 | 686 |
| Net cash provided by operating activities | 58,245 | 26,599 |
| Cash flows from investing activities | ||
| Proceeds from sales of AFS securities | 41,647 | 162,669 |
| Maturities, repayments and calls of AFS securities | 60,462 | 57,921 |
| Purchases of AFS securities | (147,333) | (190,293) |
| Net cash and cash equivalents received from acquisitions | — | 45,280 |
| Net purchases of restricted investments in bank stocks | (3,879) | (7,087) |
| Net increase in loans | (32,764) | (28,837) |
| Proceeds from sales of portfolio loans | — | 1,727 |
| Investment in limited partnerships | (1,285) | (6,891) |
| Purchases of bank premises and equipment | (3,611) | (463) |
| Proceeds from disposal of OREO and premises held for sale | 2,182 | — |
| Proceeds from disposal of premises and equipment | 18 | — |
| Purchases of bank owned life insurance | — | (5,000) |
| Death benefit proceeds from life insurance contracts | 864 | — |
| Other | (15) | (374) |
| Net cash (used in) provided by investing activities | (83,714) | 28,652 |
| continued | ||
| September 30, 2025 | September 30, 2024 | |
|---|---|---|
| Cash flows from financing activities | ||
| Net (decrease) increase in deposits | (90,387) | 145,397 |
| Net increase (decrease) in borrowings with original maturities less than 90 days | 95,538 | (18,296) |
| Proceeds from FHLB advances with original maturities greater than 90 days | 20,000 | — |
| Payments on FHLB advances with original maturities greater than 90 days | (15,000) | — |
| Payments on subordinated notes | (32,500) | — |
| Dividends paid | (15,378) | (8,722) |
| Acquisition of treasury stock | (94) | — |
| Shares repurchased as treasury stock for employee taxes associated with restricted stock vesting | (2,001) | (2,393) |
| Proceeds from issuance of employee stock purchase plan shares | 151 | 267 |
| Other | 412 | 115 |
| Net cash (used in) provided by financing activities | (39,259) | 116,368 |
| Net (decrease) increase in cash and cash equivalents | (64,728) | 171,619 |
| Cash and cash equivalents at beginning of period | 248,874 | 65,161 |
| Cash and cash equivalents at end of period | $184,146 | $236,780 |
| Nine Months Ended | ||
| September 30, 2025 | September 30, 2024 | |
| Supplemental disclosures of cash flow information: | ||
| Cash paid during the period for: | ||
| Interest | $78,082 | $63,206 |
| Income taxes | 2,200 | 6,825 |
| Supplemental schedule of noncash activities: | ||
| Premise and equipment transferred to held for sale | — | 1,925 |
| Lease liabilities arising from obtaining ROU assets | 2,010 | — |
| Noncash transactions related to merger: | ||
| Assets acquired | — | 2,154,283 |
| Liabilities assumed | — | 2,018,067 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.